In unadjusted analyses , treatment with upstream tirofiban vs eptifibatide was associated with similar rates of major bleeding ( @ % vs @ % , P = @ ) and nonsignificantly lower rates of MACE ( @ % vs @ % , P = @ ) and NACE ( @ % vs @ % , P = @ ) .